Praxsyn Corporation (PXYN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 13, 2025
Praxsyn Market Cap
Praxsyn has a market cap or net worth of $848.00 as of September 5, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
848.00
Enterprise Value
n/a
Revenue
63.50M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since August 16, 2010, Praxsyn's market cap has decreased from 46.19M to 848.00, a decrease of -100.00%. That is a compound annual growth rate of -51.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 848.00 | - |
| Dec 19, 2024 | 848.00 | - |
| Dec 29, 2023 | 848.00 | - |
| Dec 31, 2021 | 848.00 | -99.75% |
| Dec 31, 2020 | 339.18K | -93.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |